Insilico Medicine (03696.HK): Two Core Senior Executives Voluntarily Extend Lock-up Period to June 2027

NewTimeSpace · 2026/06/30 08:24 · By Xuran Lin

NewTimeSpace News: Insilico Medicine disclosed in a voluntary announcement dated June 30 that Dr. Aleksandrs Zavoronkovs, Chairman of the Board and Chief Executive Officer, and Dr. Feng Ren, Executive Director, Chief Executive Officer and Chief Scientific Officer, have voluntarily committed to extending their share lock-up arrangements. The lock-up period for all respective shareholdings held by each of them will be extended by an additional six months from the original expiry date of 29 December 2026 to 29 June 2027.

NewTimeSpace News: On 30 June 2026, Insilico Medicine (03696.HK) issued a voluntary announcement stating that the Company has recently received voluntary lock-up extension undertakings from Dr. Aleksandrs Zavoronkovs and Dr. Feng Ren. The lock-up period in respect of all shares held by each individual will be prolonged by six months, shifting from the original date of 29 December 2026 to 29 June 2027.

According to the announcement, during the extended lock-up period, the relevant shareholders shall not dispose of such shares, either directly or indirectly, in any manner whatsoever. This extension undertaking does not restrict cashless exercise or vesting under share incentive schemes, nor the previously disclosed voting proxy arrangements.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

Tags：

Insilico Medicine 03696.HK